{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:15:31Z","timestamp":1791422131114,"version":"4.3.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":975,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/jid.2012.459","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T09:29:23Z","timestamp":1354786163000},"page":"1034-1042","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Chemovirotherapy of Malignant Melanoma with a Targeted and Armed Oncolytic Measles Virus"],"prefix":"10.1016","volume":"133","author":[{"given":"Johanna K.","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Bossow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Grossardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Sawall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Kupsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Erbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Hassel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"von Kalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Enk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk M.","family":"Nettelbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Ungerechts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2012.459_bb0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2217\/imt.10.6","article-title":"New perspectives in cancer virotherapy: bringing the immune system into play","volume":"2","author":"Boisgerault","year":"2010","journal-title":"Immunotherapy"},{"key":"10.1038\/jid.2012.459_bb0015","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/cgt.2011.30","article-title":"Armed and targeted measles virus for chemovirotherapy of pancreatic cancer","volume":"18","author":"Bossow","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/jid.2012.459_bb0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2165\/11594010-000000000-00000","article-title":"Ipilimumab: first global approval","volume":"71","author":"Cameron","year":"2011","journal-title":"Drugs"},{"key":"10.1038\/jid.2012.459_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/B978-0-12-380890-5.00003-X","article-title":"Functional and clinical relevance of chondroitin sulfate proteoglycan 4","volume":"109","author":"Campoli","year":"2010","journal-title":"Adv Cancer Res"},{"key":"10.1038\/jid.2012.459_bb0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.cgt.7701110","article-title":"Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene","volume":"15","author":"Chalikonda","year":"2008","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/jid.2012.459_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.cgt.7700750","article-title":"Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization","volume":"12","author":"Conrad","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/jid.2012.459_bb0040","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1158\/1078-0432.CCR-09-2974","article-title":"Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1","volume":"16","author":"Dias","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1038\/jid.2012.459_bb0045","series-title":"Gene Ther","article-title":"Measles virus causes immunogenic cell death in human melanoma","author":"Donnelly","year":"2011"},{"key":"10.1038\/jid.2012.459_bb0050","first-page":"3813","article-title":"In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase\/uracil phosphoribosyltransferase fusion gene","volume":"60","author":"Erbs","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2012.459_bb0055","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/gt.2008.82","article-title":"Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus","volume":"15","author":"Foloppe","year":"2008","journal-title":"Gene Ther"},{"key":"10.1038\/jid.2012.459_bb0060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/sj.gt.3302148","article-title":"5-Fluorocytosine increases the toxicity of Wnt-targeting replicating adenoviruses that express cytosine deaminase as a late gene","volume":"11","author":"Fuerer","year":"2004","journal-title":"Gene Ther"},{"key":"10.1038\/jid.2012.459_bb0065","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/clpt.2010.211","article-title":"Therapeutic potential of oncolytic measles virus: promises and challenges","volume":"88","author":"Galanis","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1038\/jid.2012.459_bb0070","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1345\/aph.1Q363","article-title":"Vemurafenib (PLX4032): an orally available inhibitor of mutated BRAF for the treatment of metastatic melanoma","volume":"45","author":"Heakal","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1038\/jid.2012.459_bb0075","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/cgt.2011.6","article-title":"Comparative analysis of enzyme and pathway engineering strategies for 5FC-mediated suicide gene therapy applications","volume":"18","author":"Johnson","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/jid.2012.459_bb0080","first-page":"4921","article-title":"In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen","volume":"6","author":"Kang","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1038\/jid.2012.459_bb0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.molmed.2012.04.008","article-title":"Virus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond","volume":"18","author":"Kaufmann","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1038\/jid.2012.459_bb0090","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/cgt.2010.10","article-title":"Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy","volume":"17","author":"Li","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/jid.2012.459_bb0095","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1158\/0008-5472.CAN-08-0287","article-title":"Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature","volume":"68","author":"Maciag","year":"2008","journal-title":"Cancer Res"},{"issue":"Suppl 6","key":"10.1038\/jid.2012.459_bb0100","doi-asserted-by":"crossref","first-page":"vi1","DOI":"10.1093\/annonc\/mdp252","article-title":"Epidemiology of invasive cutaneous melanoma","volume":"20","author":"MacKie","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1038\/jid.2012.459_bb0105","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1128\/JVI.02389-05","article-title":"RNA polymerase II-controlled expression of antigenomic RNA enhances the rescue efficacies of two different members of the Mononegavirales independently of the site of viral genome replication","volume":"80","author":"Martin","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/jid.2012.459_bb0110","first-page":"5447","article-title":"Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil","volume":"61","author":"Nakamura","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2012.459_bb0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nbt1060","article-title":"Rescue and propagation of fully retargeted oncolytic measles viruses","volume":"23","author":"Nakamura","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1038\/jid.2012.459_bb0120","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nbt942","article-title":"Antibody-targeted cell fusion","volume":"22","author":"Nakamura","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1038\/jid.2012.459_bb0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ijc.11563","article-title":"Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA","volume":"108","author":"Nettelbeck","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1038\/jid.2012.459_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mam.2006.12.001","article-title":"Suicide genes for cancer therapy","volume":"28","author":"Portsmouth","year":"2007","journal-title":"Mol Aspects Med"},{"key":"10.1038\/jid.2012.459_bb0135","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/hum.2010.100","article-title":"Selectivity and efficiency of late transgene expression by transcriptionally targeted oncolytic adenoviruses are dependent on the transgene insertion strategy","volume":"22","author":"Quirin","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1038\/jid.2012.459_bb0140","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1038\/jid.2012.459_bb0145","first-page":"1393","article-title":"Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds","volume":"136","author":"Schlingemann","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2012.459_bb0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/jid.2012.459_bb0155","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/gt.2010.103","article-title":"Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics","volume":"17","author":"Ungerechts","year":"2010","journal-title":"Gene Ther"},{"key":"10.1038\/jid.2012.459_bb0160","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1158\/0008-5472.CAN-07-1252","article-title":"Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine","volume":"67","author":"Ungerechts","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2012.459_bb0165","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/sj.mt.6300291","article-title":"An immunocompetent murine model for oncolysis with an armed and targeted measles virus","volume":"15","author":"Ungerechts","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/jid.2012.459_bb0170","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/JVI.78.1.302-313.2004","article-title":"Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model","volume":"78","author":"Vongpunsawad","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/jid.2012.459_bb0175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/cgt.2011.70","article-title":"Oncolytic herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation","volume":"19","author":"Yamada","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/jid.2012.459_bb0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/cgt.2011.75","article-title":"Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD\/UPRT-armed oncolytic measles virus","volume":"19","author":"Zaoui","year":"2012","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/jid.2012.459_bb0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-61779-367-7_9","article-title":"Preclinical testing of virotherapeutics for primary and secondary tumors of the liver","volume":"806","author":"Zimmermann","year":"2012","journal-title":"Methods Mol Biol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15361662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15361662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T20:41:17Z","timestamp":1743972077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15361662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0022202X15361662"],"URL":"https:\/\/doi.org\/10.1038\/jid.2012.459","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemovirotherapy of Malignant Melanoma with a Targeted and Armed Oncolytic Measles Virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2012.459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}